UrinD/S (Llorens Pharmaceutical International Division)


Welcome to the PulseAid listing for the Urin drug offered from Llorens Pharmaceutical International Division. This Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Oxidation-Reduction Agent [EPC],Oxidation-Reduction Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Llorens Pharmaceutical International Division
NON-PROPRIETARY NAME: Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate
SUBSTANCE NAME: METHENAMINE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; PHENYL SALICYLATE; METHYLENE BLUE; HYOSCYAMINE SULFATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Oxidation-Reduction Agent [EPC],Oxidation-Reduction Activity [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 1999-05-01
END MARKETING DATE: 0000-00-00


Urin D/S HUMAN PRESCRIPTION DRUG Details:

Item DescriptionUrin D/S from Llorens Pharmaceutical International Division
LABELER NAME: Llorens Pharmaceutical International Division
DEA SCHEDULE:
ACTIVE STRENGTH: 81.6; 40.8; 36.2; 10.8; .12(mg/1; mg/1; mg/1; mg/1; mg/1)
START MARKETING DATE: 1999-05-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 54859-701_30ac92c0-60aa-4b0f-82f0-5a17f62f3702
PRODUCT NDC: 54859-701
APPLICATION NUMBER:

Other METHENAMINE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; PHENYL SALICYLATE; METHYLENE BLUE; HYOSCYAMINE SULFATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Burel Pharmaceuticals, IncURAMIT MB
Llorens Pharmaceutical International DivisionUrin
Marnel Pharmaceutical, Inc.Urimar-T
Star Pharmaceuticals LLCUstell
Star Pharmaceuticals, LLCURIBEL